We are live on ! Find out more
NECFA

New England Capital Financial Advisors Portfolio holdings

AUM $418M
1-Year Est. Return 16.7%
This Fund
S&P 500
This Quarter Est. Return
+11.53%
1 Year Est. Return
+16.7%
3 Year Est. Return
+55.56%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$166M
AUM Growth
+$21.4M
Cap. Flow
+$4.68M
Cap. Flow %
2.81%
Top 10 Hldgs %
74.92%
Holding
418
New
20
Increased
125
Reduced
48
Closed
17

Top Buys

Rank Stock Value
1
CGCP icon
Capital Group Core Plus Income ETF
CGCP
+$2.76M
2
SPDW icon
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
+$502K
3
HUBB icon
Hubbell
HUBB
+$380K
4
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$323K
5
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$241K

Top Sells

Rank Stock Value
1
CGGR icon
Capital Group Growth ETF
CGGR
+$300K
2
XLRE icon
State Street Real Estate Select Sector SPDR ETF
XLRE
+$239K
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$95.6K
4
SLYV icon
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
+$27.9K
5
SPLK
Splunk Inc
SPLK
+$25.6K

Sector Composition

Rank Sector Weight
1 Industrials 2.55%
2 Technology 1.99%
3 Healthcare 1.93%
4 Financials 1.72%
5 Consumer Staples 1.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IAGG icon
401
iShares Core International Aggregate Bond Fund
IAGG
$11.4B
– –
-94
Closed -$4.6K
MMYT icon
402
MakeMyTrip
MMYT
$5.67B
– –
-112
Closed -$4.54K
BINI
403
DELISTED
Bollinger Innovations
BINI
– –
0
– -$1
PPT
404
Franklin Premier Income Trust
PPT
$330M
– –
-4
Closed -$13
RHP icon
405
Ryman Hospitality Properties
RHP
$7.82B
– –
-10
Closed -$852
SBFM
406
Sunshine Biopharma
SBFM
$2.88M
– –
0
– -$160
TS icon
407
Tenaris
TS
$26.8B
– –
-120
Closed -$3.79K
UNG icon
408
United States Natural Gas Fund
UNG
$500M
– –
-19
Closed -$513
USFD icon
409
US Foods
USFD
$24B
– –
-50
Closed -$1.99K
VRTX icon
410
Vertex Pharmaceuticals
VRTX
$133B
– –
-275
Closed -$95.6K
XLE icon
411
State Street Energy Select Sector SPDR ETF
XLE
$39.9B
– –
-2
Closed -$91
IRD
412
Opus Genetics
IRD
$313M
– –
-20
Closed -$67
FNGA
413
DELISTED
MicroSectors FANG+ Index 3X Leveraged ETNs due January 8, 2038
FNGA
– –
-27
Closed -$4.05K
TLIS
414
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
– –
-1
Closed -$6
SPLK
415
DELISTED
Splunk Inc
SPLK
– –
-175
Closed -$25.6K
VMW
416
DELISTED
VMware, Inc
VMW
– –
-13
Closed -$2.17K
TWNK
417
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
– –
-548
Closed -$18.3K
ATHX
418
DELISTED
Athersys, Inc. Common Stock
ATHX
– –
-40
Closed -$18
13 14 15 16
17

Similar funds

VIS
Vega Investment Solutions Paris, France $418M AUM
PIMC
Praesidium Investment Management Company New York $419M AUM 4.58% 1-Year Est. Return
DBRC
D.B. Root & Company Pittsburgh, Pennsylvania $419M AUM 15.03% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return
ACM
Alight Capital Management New York $417M AUM 98.18% 1-Year Est. Return
CMHI
CVC Management Holdings II St. Helier, Jersey $420M AUM 0.05% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM

New England Capital Financial Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, New England Capital Financial Advisors held 418 positions worth $166M, up 15% from $145M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

New England Capital Financial Advisors's Q4 2023 filing shows 20 new, 125 increased, 48 reduced and 17 closed positions. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 101 shares worth $24K. The largest sale was Capital Group Growth ETF, an estimated $300K.

By sector, the portfolio is most concentrated in Industrials at 2.6% of assets, up from 2.3% a quarter earlier, followed by Technology and Healthcare.

  • New England Capital Financial Advisors's largest Q4 2023 buy was Vanguard Morningstar Total Stock Market ETF: 101 shares worth $24K.
  • New England Capital Financial Advisors added most to Capital Group Core Plus Income ETF in Q4 2023, an estimated $2.76M increase.
  • New England Capital Financial Advisors's biggest Q4 2023 reduction was Capital Group Growth ETF, cutting an estimated $300K.
  • New England Capital Financial Advisors fully exited Vertex Pharmaceuticals in Q4 2023, selling an estimated $95.6K.
  • New England Capital Financial Advisors's ten largest holdings make up 75% of its $166M portfolio in Q4 2023.
  • New England Capital Financial Advisors opened 20 new positions and closed 17 in Q4 2023.
  • New England Capital Financial Advisors's portfolio value rose 15% quarter-over-quarter to $166M.

Based on New England Capital Financial Advisors's 13F filing for Q4 2023, filed 1 Feb 2024.